التفاصيل البيبلوغرافية
| العنوان: |
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. |
| المؤلفون: |
Salter, Alexander I., Ivey, Richard G., Kennedy, Jacob J., Voillet, Valentin, Rajan, Anusha, Alderman, Eva J., Voytovich, Uliana J., Lin, Chenwei, Sommermeyer, Daniel, Liu, Lingfeng, Whiteaker, Jeffrey R., Gottardo, Raphael, Paulovich, Amanda G., Riddell, Stanley R. |
| المصدر: |
Science Signaling; 8/21/2018, Vol. 11 Issue 544, p1-N.PAG, 17p |
| مصطلحات موضوعية: |
ANTIGEN receptors, T cells, PHOSPHORYLATION, B cells, MUTAGENESIS |
| مستخلص: |
Chimeric antigen receptors (CARs) link an antigen recognition domain to intracellular signaling domains to redirect T cell specificity and function. T cells expressing CARs with CD28/CD3ς or 4-1BB/CD3ς signaling domains are effective at treating refractory B cell malignancies but exhibit differences in effector function, clinical efficacy, and toxicity that are assumed to result from the activation of divergent signaling cascades. We analyzed stimulation-induced phosphorylation events in primary human CD8+ CD28/CD3ς and 4-1BB/CD3ς CAR T cells by mass spectrometry and found that both CAR constructs activated similar signaling intermediates. Stimulation of CD28/CD3ς CARs activated faster and larger-magnitude changes in protein phosphorylation, which correlated with an effector T cell-like phenotype and function. In contrast, 4-1BB/CD3ς CAR T cells preferentially expressed T cell memory-associated genes and exhibited sustained antitumor activity against established tumors in vivo. Mutagenesis of the CAR CD28 signaling domain demonstrated that the increased CD28/CD3ς CAR signal intensity was partly related to constitutive association of Lck with this domain in CAR complexes. Our data show that CAR signaling pathways cannot be predicted solely by the domains used to construct the receptor and that signal strength is a key determinant of T cell fate. Thus, tailoring CAR design based on signal strength may lead to improved clinical efficacy and reduced toxicity. [ABSTRACT FROM AUTHOR] |
|
Copyright of Science Signaling is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
